<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01317693</url>
  </required_header>
  <id_info>
    <org_study_id>0571-10-RMB</org_study_id>
    <nct_id>NCT01317693</nct_id>
  </id_info>
  <brief_title>Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction</brief_title>
  <official_title>Extracorporeal Shock Wave Therapy With a Wide Focus Probe for the Treatment of Erectile Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered to the penile
      tissue. Shockwaves are created by a special generator and are focused using a specially
      designed shockwave applicator apparatus. The shockwaves are delivered through the applicator
      covering the corpora cavernosa of the penis. In previous studies the investigators used a
      medium focused probe and in this study the investigators are evaluating results of this
      therapy using a wider focus probe in the aim of improving results of treatment.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in IIEF-ED Domain Questionaire Score &gt; 5 points is considered treatment success</measure>
    <time_frame>13 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rigidity Score Questionaire- an increase by at least 1 point is considered success</measure>
    <time_frame>13 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Treatment LI-ESWT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device: Extracorporeal Shockwave Therapy Generator (Omnispec model ED1000) Gel is spread around the penis and on the Shock Wave applicator and Treatment (12 sessions in total) of 300 shocks per site, on 5 penile anatomical sites.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Low intensity shock waves</intervention_name>
    <description>1500 shocks, Energy Density - 0.09 mJ/mm2</description>
    <arm_group_label>Treatment LI-ESWT</arm_group_label>
    <other_name>Omnispec model ED1000</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ED of more than 6 months

          -  At least 50% unsuccessful to attempt sexual intercourse for 4 times at 4 different
             days

          -  Positive response to PDE-5 inhibitors

          -  IIEF-5 domain score of 12-20 denoting mild to severe ED

          -  Non-Neurological pathology

          -  Stable heterosexual relationship for more than 3 months

        Exclusion Criteria:

          -  NPT - normal/flat

          -  Prior prostatectomy surgery

          -  Any cause of ED other than vascular related

          -  Any unstable medical, psychiatric, spinal cord injury, penile anatomical abnormalities

          -  Clinically significant chronic hematological disease

          -  Cardiovascular conditions that prevent sexual activity

          -  History of heart attack, stroke or life-threatening arrhythmia within the prior 6
             months.

          -  Cancer within the past 5 years.

          -  Anti-androgens, oral or injectable androgens

          -  Use of any treatment for ED within 7 days of screening including oral medications,
             vacuum devices, constrictive devices, injections or urethral suppositories
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilan Gruenwald, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yoram Vardi, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ilan Gruenwald, MD</last_name>
    <phone>00972-4-8542882</phone>
    <email>i_gruenwald@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam Medical Center</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilan Gruenwald, MD</last_name>
      <phone>00972-4-8542882</phone>
      <email>i_gruewald@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Yoram Vardi, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilan Gruenwald, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boaz Appel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yaron Ofer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suliman Nassar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Omar Massarwa, RN BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ezra Gerber, RN BA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2011</study_first_submitted>
  <study_first_submitted_qc>March 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 17, 2011</study_first_posted>
  <last_update_submitted>December 18, 2012</last_update_submitted>
  <last_update_submitted_qc>December 18, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>i_gruenwald</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>LI-ESWT</keyword>
  <keyword>Erectile Dysfunction</keyword>
  <keyword>ED</keyword>
  <keyword>Shock waves</keyword>
  <keyword>Therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

